Jill O'Donnell-Tormey, PhD, CEO and director of scientific affairs, is a panelist on the "Public-Private Partnerships Between Research Organizations and BioPharma to Accelerate Cancer Immunotherapies" on October 2, 2020, at 1 PM ET.
The Fifth Annual IO Combinations 360° program addresses clinical advancements, scientific data, and business aspects in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer.
The Fifth Annual IO Combinations 360° will take place October 1-2, 2020, virtually on Eastern Standard Time.
Exclusive for Cancer Research Institute Community
10% discount for IO Combinations 360° Virtual with code CRI10
